Latent Tuberculosis Infections in Different Intensity of Exposure within Moroccan Population: Influence of Age and Bacille Calmette-Guérin Vaccination
- PMID: 39700159
- DOI: 10.4103/ijmy.ijmy_174_24
Latent Tuberculosis Infections in Different Intensity of Exposure within Moroccan Population: Influence of Age and Bacille Calmette-Guérin Vaccination
Abstract
Background: In Morocco, latent tuberculosis infection (LTBI) is a public health concern affected by the country's location as transit area between sub-Saharan Africa with high TB burden to Europe. This study aimed to assess the influence of exposure intensity to Mycobacterium tuberculosis (Mtb), age, and Bacille Calmette-Guérin (BCG) vaccination on LTBI prevalence in Morocco.
Methods: A cross-sectional study of 131 participants, including 98 non-exposed healthy volunteers (NEHV) and 33 healthcare workers exposed to active TB (exposed healthcare workers [EHCW]), was conducted. The Interferon-γ Release Assay (IGRA) was used to detect LTBI, and results were analyzed according to participants' age and BCG vaccination status.
Results: EHCW showed a higher prevalence of LTBI than NEHV (36.7% vs. 57.6%) and of EHCW were positive for LTBI. In both groups, the mean age of those with LTBI was higher than those without. Furthermore, we showed within both groups, that LTBI prevalence was positively associated with subjects less covered by BCG vaccination in comparison with subjects likely totally covered by this vaccination (adjusted odds ratio [aOR], 2.783; 95% confidence intervals [CI], 1.180-6.57; P = 0, 01), (aOR, 6.717; 95% CI, 1.254-35.977; P = 0.02).
Conclusion: Our results showed that in the Moroccan TB epidemic context, the prevalence of LTBI still lower among healthy adults general population than within EHCW. Furthermore, this LTBI showed to be positively impacted by age in the two condition of exposure. We also showed that BCG vaccination seems to affect the prevalence of LTBI within both high and low intensity of exposure to Mtb infection.
Copyright © 2024 International Journal of Mycobacteriology.
References
REFERENCES
-
- Krachunov II, Ivanov YY. Reactivation of tuberculosis in patient treated with the antifibrotic drug nintedanib. Int J Mycobacteriol 2022;11:454-6.
-
- Tuberculosis (TB). Available from: https://www.who.int/news-room/fact-sheets/detail/tuberculosis. [Last accessed on 2024 Aug 05].
-
- Ghanavi J, Farnia P, Farnia P, Velayati AA. Human genetic background in susceptibility to tuberculosis. Int J Mycobacteriol 2020;9:239-47.
-
- Verrall AJ, Netea MG, Alisjahbana B, Hill PC, van Crevel R. Early clearance of Mycobacterium tuberculosis: A new frontier in prevention. Immunology 2014;141:506-13.
-
- Stein CM, Zalwango S, Malone LL, Thiel B, Mupere E, Nsereko M, et al. Resistance and susceptibility to Mycobacterium tuberculosis infection and disease in tuberculosis households in Kampala, Uganda. Am J Epidemiol 2018;187:1477-89.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical